Article Details
Retrieved on: 2024-10-19 13:37:46
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Roche's ELEVATUM study on faricimab (Vabysmo) for diabetic macular edema, highlighting significant vision improvements and central subfield thickness reduction in underrepresented populations. The study's findings link to angiogenesis inhibitors, diabetic retinopathy, and macular conditions.
Article found on: www.ophthalmologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here